MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

BMRN — BioMarin Pharmaceuticals Inc

Nasdaq

BioMarin Pharmaceuticals Inc

CompareBack to Screener
$57.18
-1.26(-2.16%)
O
58.52
H
58.73
L
57.15
V
2.19M
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

BioMarin Pharmaceuticals Inc Statistics

Total Valuation

Market Cap$11.66B
Enterprise Value$11.59B

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding193.57M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ratio105.89
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ratio17.81
P/TBV Ration/a
P/FCF Ratio584.03
P/OCF Ratio552.06
PEG Ration/a

Enterprise Valuation

EV / Earnings1,097.87
EV / Salesn/a
EV / EBITDA671.35
EV / EBIT741.90
EV / FCF580.07

Financial Position

Current Ratio5.81
Quick Ration/a
Debt / Equity0.23
Debt / EBITDA8.29
Debt / FCF7.16
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)1.70%
Return on Assets (ROA)1.23%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$3,276
Employee Count3,221
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Tax$35.68M
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change+2.90%
50-Day Moving Average$63.98
200-Day Moving Average$58.67
Relative Strength Index (RSI)10.92
Average Volume (20 Days)2,021,003

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$57.12M
Operating Income$12.96M
Pretax Income$14.12M
Net Income$10.55M
EBITDA$17.26M
EBIT$15.62M
Earnings Per Share$0.54

Balance Sheet

Cash & Cash Equivalents$222.24M
Total Debt$143.03M
Net Cash$79.22M
Net Cash Per Share$0.41
Equity (Book Value)$621.21M
Book Value Per Share$3.21
Working Capital$381.19M

Cash Flow

Operating Cash Flow$21.13M
Capital Expenditures-$20.92M
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow$19.97M
FCF Per Share$0.10

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yield0.94%
FCF Yield0.17%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Value$8.10
Lynch Upside-85.83%
Graham Number$6.25
Graham Upside-89.07%

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a